[Effect of carbonic anhydrase inhibitor, benzanilamide, on activity of carbonic anhidrase in the ciliary body and intraocular pressure of glaucomatous eyes].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000818:Animals; D002257:Carbonic Anhydrase Inhibitors; D002256:Carbonic Anhydrases / Q000378:metabolism*; D002648:Child; D002713:Chlorine / Q000097:blood; D002924:Ciliary Body / Q000201:enzymology*; D003864:Depression, Chemical; D005260:Female; D005901:Glaucoma / Q000188:drug therapy / Q000201:enzymology*; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects*; D008297:Male; D008875:Middle Aged; D011188:Potassium / Q000097:blood; D011817:Rabbits; D012964:Sodium / Q000097:blood; D013449:Sulfonamides / Q000494:pharmacology* / Q000627:therapeutic use*
D002257:Carbonic Anhydrase Inhibitors; D013449:Sulfonamides; D002713:Chlorine; D012964:Sodium; D002256:Carbonic Anhydrases; D011188:Potassium